Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 7 | Journal of Neuroinflammation

Fig. 7

From: Ammoxetine attenuates diabetic neuropathic pain through inhibiting microglial activation and neuroinflammation in the spinal cord

Fig. 7

Effects of ammoxetine on the activation of BV-2 cells induced by LPS. a Cell viability after treated with various concentration of ammoxetine for 24 h. b Representative images of IBA-1 stained BV-2 microglial cells 24 h after LPS and/or ammoxetine incubation. c Quantification of average intensity in 3 independent images. d TNF-α production in the culture medium of BV-2 cells after treated with LPS or ammoxetine (n = 3). #P < 0.05 compared with the control group. *P < 0.05 compared with the LPS-treated group

Back to article page